In order to prove the intake of a newly encountered designer drug, Methylone, a sensitive and useful method, which allows us to simultaneously detect Methylone and its metabolites in human urine, has been established by means of a combination of gas chromatography-mass spectrometry (GC MS) and high-performance liquid chromatography-electrospray ionization mass spectrometry (LC ESI MS). GC MS accompanied with tri‰uoroacetyl (TFA) derivatization and LC MS analyses were performed following acid hydrolysis and liquid-liquid extraction with a chloroform 2 propanol mixture (31, v/v). Methylone and its metabolites, 3,4 methylenedioxycathinone ( MDC ) , 4 hydroxy 3 methoxymethcathinone (HMMC) and 3 hydroxy 4 methoxymethcathinone (3 OH 4 MeO MC) could be satisfactorily separated on a semi-micro ODS column using linear gradient elution with a binary mobile phase of methanol and 10 mM ammonium formate buŠer (pH 3.5).
Introduction
Methylone [ 2 methylamino 1 ( 3,4  methylenedioxyphenyl)propan 1 one], the b keto analogue of 3,4  methylenedioxymethamphetamine (MDMA), increases the concentrations of monoamine neurotransmitters such as serotonin, dopamine and noradrenaline in the human synaptic cleft through the inhibition of the plasma membrane monoamine reuptake transporters 1 3) . This would lead to stimulating the central nervous system and hallucinogenic eŠect 4) . Methylone wasˆrst synthesized as an antidepressant and anti-Parkinsonism agent by Jacob et al. in 1996 5) , and its amphetamine-like and MDMA like characteristics had also been reported 4) . More recently, it has been encountered in the Japanese drug market as well as in Europe under the name of``Explosion'' 6) . The drug has been sold in the powder or liquid form mainly on the Internet, and has been increasingly abused as a new designer drug. Thereby, intoxication due to its overdosing has also been reported. However, this drug is not currently classiˆed as an illegal drug, and no one prevents their sale and abuse; thus there is much apprehension about its popularity in Japan and Europe.
In a previous study, the chemical, physical and analytical characterization of methylone as one of the methylenedioxycathinone homologues was reported: Methylone gave an intensive yellow color and a weak blue color with Marquis' reagent and Shimon's reagent on the presumptive test, respectively 7) . However, with regard to its metabolism, no report has been published. Thus, immediate studies on these subjects have been demanded in the forensic toxicology and clinical chemistry.
For unequivocal proof of the intake of methylone, the identiˆcation of its principal metabolites in humans and the establishment of the determination procedures for its metabolites in biological samples including urine and blood are indispensable. In the previous studies, on the metabolism of MDMA and 3,4 methylenedioxy  a pyrrolidinopropiophenone (MDPPP) that possess almost the same structure as methylone, several metabolic routes in humans have been reported 8 10) . Based on these reports, 3,4 methylenedioxycathinone (MDC), 4 hydroxy 3  methoxymethcathinone (HMMC) and 3 hydroxy 4 methoxymethcathinone (3 OH 4 MeO MC) were expected as the signiˆcant urinary metabolites, which retained the structural characteristics of the parent drug methylone.
More recently, we have achieved the identiˆcation of the urinary metabolites of methylone in rats and humans using their synthesized authentic standards (Fig. 1) 11) . Moreover, urinary excretion proˆles of methylone and its metabolites in rats were clariˆed: The cumulative amount of methylone and its metabolites excreted in urine within 48 hr were 3 of the dose for methylone, 2 for MDC, 26 for HMMC, and 5 for 3 OH 4 MeO MC. Based on these data, the demethylenated metabolites were considered to be the relevant target analytes to be detected in order to prove the intake of methylone.
In the present study, we established the sensitive and useful assay for the simultaneous determination of methylone and its main urinary metabolite, HMMC along with the minor metabolites, MDC and 3 OH 4 MeO MC in human urine by means of combination of GC MS for identiˆcation and LC  MS for quantiˆcation and further conˆrmation.
Experimental

Materials
Methylone [ 2 methylamino 1 ( 3,4  methylenedioxyphenyl ) propan 1 one ] hydrochloride was synthesized in our laboratory according to the previously published method 5) with partial modiˆcation.
were all chemically synthesized in our laboratory as reported in our previous paper (The chemical structures are shown in Fig. 1) 11) . The standard stock solutions of these four compounds were prepared in distilled water (1 mg/ml each), and these solutions were then diluted to appropriate concentrations with distilled water or control human urine immediately prior to use. The internal standard (I.S.), b phenethylamine (PEA), was purchased from Tokyo Kasei (Tokyo, Japan), and the I.S. solution (1 mg/ml) was prepared in the mobile phase for LC MS. Methanol was of HPLC grade, and all other chemicals were of analytical grade.
Tri‰uoroacetic anhydride (TFAA) used for the tri‰uoroacetyl (TFA) derivatization was purchased from Wako (Osaka, Japan). Sample preparation 1) Acid hydrolysis To 1 ml of each urine sample, 1 ml of a 1.2 M HCl aqueous solution was added, and the mixture was then heated at 100°C for 1 h. The reaction mixture was cooled and subsequently neutralized with 28 ammonium hydroxide. The resultant solution was subjected to liquid liquid extraction as described below.
2) Extraction and TFA derivatization for GC MS Before or after the hydrolysis, 1 ml of each urine sample was adjusted to pH 9 with 28 ammonium hydroxide and saturated with NaCl. The solution was extracted three times with 1 ml of a chloroform 2 propanol mixture (31, v/ v), and the organic layer was separated after centrifugation at 1500× . The combined extract was dried with anhydrous Na 2 SO 4 , transferred into a screw-capped glass tube, and dried under a gentle stream of nitrogen. The residue was derivatized by adding 200 ml of TFAA and 200 ml of ethylacetate at 80°C for 1 h. The reaction mixture was carefully evaporated to dryness under a gentle stream. The residue was reconstituted in 100 ml of ethylacetate, and a 1 ml aliquot was then injected into the GC MS system.
3) Extraction for LC MS
The extraction from each urine sample for LC MS was performed in the same procedure as that for GC MS, and each extract obtained from urine was dissolved in 100 ml of I.S. solution. This was thenˆltered through a 0.2 mm membraneˆlter, and an aliquot of 5 ml was automatically injected into the LC MS system. Instruments 1) GC MS GC MS was carried out using a Shimadzu GCMS QP 2010 (Shimadzu, Kyoto, Japan). A DB 5ms fused-silica capillary column (column dimensions andˆlm thickness: 0.25 mm i.d. × 30 m and 0.25 mm; J & W Scientiˆc, Rancho Cordova, CA, USA) was employed for the separation. Injections were automatically done in the splitless mode at 260°C. The column oven temperature was maintained at 80°C for 2 min and then raised at 15°C/min to 320°C. The temperature of the transfer line was set at 250°C, and high purity helium, at the ‰ow rate of 1 ml/ min, was used as the carrier gas. The EI operating parameters were as follows: source temperature, 200°C; electron energy, 70 eV; ion multiplier gain, 1.2 kV. Data were collected from m/z 40 500 at the scan rate of 0.5 s/scan.
2) LC MS
LC MS was performed using a Shimadzu LCMS 2010A high-performance liquid chromatograph-mass spectrometer equipped with an SIL HTc auto sampler, three LC 10AD pumps, a CTO 10A column oven and an ESI interface (Shimadzu, Kyoto, Japan). The ESI MS was performed in the positive mode under the following operating parameters: probe voltage, 4.5 kV; nebulizer nitrogen gas, 1.5 l/ min; curved desolvation line ( CDL ) temperature, 200°C; Q array DC, 10 V; Q array RF, 150 V.
The quantitative measurements were accomplished in the SIM mode by monitoring three ions for the analytes (m/z 208 for methylone, m/z 194 for MDC, m/z 210 for HMMC and 3 OH 4 MeO MC, and m/z 122 for I.S.) using an absolute calibration method.
Each 30 min chromatographic run was carried out using a linear gradient elution with a binary mobile phase of methanol (5 to 40) and 10 mM ammonium formate buŠer (pH 3.5). The column used was a semi-micro L column ODS (1.5 mm i.d. ×150 mm, Chemicals Evalution and Research Institute, Tokyo, Japan) and the ‰ow rate was set at 0.1 ml/min.
Results and Discussion
Acid hydrolysis
The demethylenated and successive O methylated metabolites of methylone, HMMC and 3 OH 4 MeO MC, were expected to be extensively conjugated into their sulfates and/or glucuronides in vivo and then excreted into the urine. Methylone and its demethylated metabolite MDC were also expected to be O conjugated after enolation 11) . In order to determine the total metabolites as free bases, hydrolysis of the conjugates was required before the extraction. For the rapid and complete hydrolysis of the conjugates of the hydroxylated metabolites of the phenethylamine derivatives, acid hydrolysis has been used as e‹cient method than enzymatic hydrolysis 10, 12) . Therefore, we chose the acid hydrolysis and explored the optimization of the hydrolysis conditions for the conjugates in the present study.
In our previous study on the metabolism of methamphetamine and MDMA, it was indicated that a 1.2 M HCl aqueous solution was available and eŠective for acid hydrolysis of the p hydroxymethamphetamine and 4 hydroxy 3 methoxymethamphetamine ( HMMA ) conjugates 10) . In the present study, the hydrolysis condition was optimized using a 1.2 M HCl solution. As the sample to be hydrolyzed, rat urine collected from a rat administered a single intraperitoneal dose of 5 mg / kg methylone was employed. To 1 ml of the urine samples was added 1 ml of 1.2 M HCl solution, the incubation time and temperature were varied, and then the urinary levels of the free methylone, MDC, HMMC and 3 OH 4 MeO MC were measured.
As the results, the levels of the four compounds all increased with time up to approximately 1 h at 100°C, and then showed no noticeable change. This suggests that the glucuronides and sulfates were completely hydrolyzed at 100°C within 1 h. In order to examine the stability of the four compounds during the hydrolysis, a blank urine sample spiked with the four compounds was heated at 100°C for 1 h. No noticeable decrease was detected for all of the four compounds. Thus, wê nally selected the hydrolysis temperature of 100°C and hydrolysis time of 1 h.
GC MS following TFA derivatization
Derivatization is often a successful procedure for the sensitive GC MS analysis of hydroxylated compounds. For sensitive analysis of hydroxylated metabolites of the amphetamine analogues, derivatization, including ethylation 8) , trimethylsilylation 8, 13) , acetylation 14 16) , tri‰uoroacetylation 17) , a n d hepta‰uorobutylation 12) , were successfully used. In our preliminary experiment, the TFA derivatization was selected, and was applied to methylone and its metabolites, MDC, HMMC The extract obtained from the spiked human urine sample after the liquid-liquid extraction was subjected to GC MS after TFA derivatization under the optimized condition. The extracted mass chromatograms and the mass spectra are depicted in Fig. 2 and Fig. 3 , respectively. Under the present conditions, the TFA derivatives of the structural isomers, HMMC and 3 OH 4 MeO MC, were detected as well-separated peaks, and easy distinction between the isomers was possible based on their retention times.
EI mass spectra of the TFA derivatives of the four analytes were characterized by the predominant ion due to the b cleavage of benzene ring moieties (m/z 149 for methylone and MDC, and m/z 247 for HMMC and 3 OH 4 MeO MC) and/or to the a cleavage of amine moieties (m/z 154 for HMMC and 3 OH 4 MeO MC), and some other ions including a less intensive molecular ion M ＋ (m/z 303 for methylone, 289 for MDC and 401 for HMMC and 3 OH 4 MeO MC).
The mass spectra of the two isomers of HMMC and 3 OH 4 MeO MC were very similar, but a signiˆcant diŠerence in the relative intensity of the two ions at m/z 154 and 247 between the isomers appeared in their mass spectra. Therefore, the isomers may be distinguishable based only on their spectra. However, as described above, the retention times of the isomers will allow a quick discrimination of the isomers, and the combination of the retention time and mass spectral information would lead to a more reliable discrimination of the isomers by GC MS.
For the scan mode, the detection limits were found to be 5 ng/ml for methylone, 10 ng/ml for MDC, 25 ng/ml for HMMC, and 25 ng/ml for 3 OH 4 MeO MC, at which the three most intense ions in each mass spectrum could be observed and the noise intensity from the background was about the same as that of the least intense ion of the three target ions in each background-subtracted mass spectrum. When the SIM technique with each molecular ion was applied, the detection limits were 0.5 ng/ml for methylone, 0.5 ng/ml for MDC, 2.5 ng/ml for HMMC, and 2.5 ng/ml for 3 OH 4 MeO MC based on an S/N ratio of ca. 3.
With further exploration, the GC MS analysis after the TFA derivatization was found to show a relatively low reproducibility especially for HMMC and 3 OH 4 MeO MC, compared with LC MS analysis. This suggests that the GC MS technique accompanied with TFA derivatization would not be preferable for the quantitative analysis of the demethylenated and methylated metabolites.
Chromatographic condition for LC MS
In order to determine methylone and its three metabolites simultaneously, we explored the optimization of the eluent using a semi-micro ODS column. In the present study we have focused on the free form of analytes, however, in future studies analyses of the conjugates, i.e. glucuronide and sulfate, of methylone metabolites will be required. On the basis of our previous analytical studies of the conjugates of p hydroxymethamphetamine 18) , in which the conjugates have been impractically retained on the ODS column in an isocratic mode, a linear gradient elution has been explored. Using a linear gradient elution with a binary mobile phase of methanol (5 to 40) and 10 mM ammonium formate buŠer (pH 3.5), all the four analytes were eluted in well separated peaks within 20 min (Fig. 4) . Thus, weˆnally chose this gradient eluent system for the present study.
Condition for ESI MS
In order to optimize the operating parameters of the ESI MS for the four analytes, the probe, CDL and Q array voltages were varied, and the abundance of each protonated molecule [M＋ H] ＋ was measured. At the probe, the CDL and Q array voltages of 4.5 kV, 30 V and 10 V, respectively, the highest abundance was achieved. Thus, weˆnally selected these parameters for the ESI MS.
The mass spectra obtained under the optimized conditions are presented in Fig. 5 . All of their mass spectra were characterized by each predominant [M＋H] ＋ at m/z 208 for ＋ (m/z 190 for methylone, 176 for MDC, and 192 for HMMC and 3 OH 4 MeO MC) also appeared in every mass spectrum. However, the mass spectra of HMMC and 3 OH 4 MeO MC were very similar, and their retention characteristics will, therefore, be helpful in discriminating these isomers.
Extraction recoveries
The simultaneous extraction of methylone and its metabolites, MDC, HMMC and 3 OH 4 MeO MC, was explored by the liquid-liquid extraction with a chloroform  2  propanol mixture (31, v/v). In the present study, a saturated volume of NaCl was added for saltingout and the eŠects were tested. As urine samples, drug-free urine from a healthy volunteer, spiked with standard analytes in concentration of 50 ng / ml and 500 ng / ml, were employed. Extraction was conducted according to the procedure described in Experimental section, and each extract was subjected to LC MS in the SIM mode by monitoring each [M＋H] ＋ . The extraction recoveries were estimated by comparing the peak area ratios (analyte versus I.S.) from the spiked urine samples with those from standard aqueous solutions at the same concentration for each analyte.
As summarized in Table 1 , the addition of NaCl led to higher recoveries for all the analytes. A signiˆcant improvement in the recovery was especially obtained for HMMC. Thus, the liquid-liquid extraction with a chloroform 2 propanol mixture (31, v/v) following the addition of a saturated volume of NaCl gave su‹cient recoveries for all the analytes.
Quantitative analysis
Quantitative measurements were carried out in the presence of the internal standard, PEA, using LC MS in the SIM mode: The [M＋H] ＋ of each analyte (m/z 208 for methylone, 194 for MDC, 210 for HMMC and 3 OH 4 MeO MC, and 122 for PEA) were monitored, and the linearity and reproducibility were evaluated for drug-free urine samples spiked with known concentrations of analytes (n＝5).
The LC MS showed a good linearity throughout the concentration range from 25 to 500 ng/ml for methylone, HMMC and 3 OH 4 MeO MC, and from 50 to 1000 ng/ml for MDC (methylone; y＝1.30×10 -2 x＋0.370, r 2 ＝0.995, MDC; y＝2.55×10 -3 x-7.9×10 -3 , r 2 ＝0.999, HMMC; y＝5.41×10 -3 x＋0.171, r 2 ＝0.999, 3 OH 4 MeO MC; y＝6.65×10 -3 x＋1.6×10 -3 , r 2 ＝0.999). As summarized in Table 2 , the within-day relative standard deviations (RSDs) and the accuracy for all the analytes ranged from 6.6 to 10.5 and from 88 to 119 at the concentration of 50 ng/ml, and from 1.4 to 6.8  and from 99 to 104 at 500 ng/ml, respectively. The between-day RSDs determined from three batches over 3 days (n＝3, for each batch) at the concentration of 500 ng/ml were calculated to be 2.9 for methylone, 4.4 for MDC, 8.0 for HMMC and 8.7 for 3 OH 4 MeO MC.
Furthermore, for the LC ESI MS in the full scan mode, the detection limits were found to 25 ng/ml for methylone, 100 ng/ml for MDC, 50 ng/ml for HMMC, and 25 ng/ml for 3 OH 4 MeO MC: At the each detection limit, each [M ＋H] ＋ ion could be observed and the intensities were about the same as those of the background noises in each background subtracted mass spectrum. The SIM technique by monitoring each [M＋H] ＋ further reduced the detection limits to 2.5 ng/ml for methylone, 25 ng/ml for MDC, 10 ng/ml for HMMC, and 5 ng/ml for 3 OH 4 MeO MC based on an S/N ratio of ca. 3. These results indicated that the present technique gave a high sensitivity.
Conclusion
A useful analytical method for the simultaneous determination of methylone and its speciˆc metabolites, MDC, HMMC and 3 OH 4 MeO MC, in human urine was developed using GC MS and LC ESI MS analyses. A coupling of the acid hydrolysis, liquid liquid extraction with a chloroform  2  propanol mixture (31, v/v), TFA derivatization for GC MS, and LC separation on a semi-micro ODS column produced a convenient pretreatment, good recoveries and high sensitivity.
GC MS after the TFA derivatization produced many more structural fragment ions that were favorable for the identiˆcation, but had found to show a relatively low reproducibility especially for HMMC and 3 OH 4 MeO MC. On the other hand, the LC MS allowed an accurate quantiˆcation of these metabolits. In addition, the identiˆcation of analyte by use of more than one technique is preferable for positive proof of abuse of illicit drugs in forensic toxicology, if possible. Thus, we recommend the combination of GC MS for identiˆcation and LC MS for more reliable quantiˆcation and further conˆrmation of GC MS results in the analysis of urinary methylone and its metabolites. The developed methods in the present study would serve as useful tools in drug enforcement and clinical treatment that requires unequivocal proof of the intake of methylone.
The abuse of new phenethylamine derivatives, which possess methylenedioxy and/ or b keto moieties, as recreational drugs will be encountered. However, the present study will provide useful information regarding the urine analysis for these drugs.
